Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Eli Lilly and Company is currently researching a dual agonist called tirzepatide, which has outperformed semaglutide in phase 3 clinical trials
If you experience side effects that concern you, discuss them with your GP or practice nurse
Research indicates GHK-Cu demonstrates superior efficacy in reducing wrinkle depth and improving skin elasticity
GHK Peptide as a Natural Modulator of Multiple Cellular Functions (Pickart et al., 2015) This paper reviews clinical research showing that topical GHK-Cu can tighten skin, improve elasticity, reduce fine lines and wrinkles, and enhance skin clarity and density
US$ 24.49
US$ 23.78
US$ 28.82
US$ 24.45
US$ 27.95
US$ 20.23
US$ 27.63
US$ 27.67
US$ 26.94
US$ 26.61
US$ 23.34
